IBB vs SCHA

iShares Biotechnology ETF vs Schwab US Small-Cap ETF

Quick take
  • • SCHA has the lower expense ratio at 0.03% vs 0.44% for IBB.
  • • SCHA pays a higher dividend yield (1.12%).

Side-by-side metrics

MetricIBBSCHA
Expense ratio
Annual fee. Lower is better.
0.44%0.03%
Dividend yield
Trailing 12-month yield.
0.16%1.12%
AUM
Assets under management — bigger funds are typically more liquid.
$11.50B$22.04B
YTD return
30.22%18.09%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.601.23
P/E ratio
25.4816.37
Last price
$217.75$33.55
Inception
——
Issuer
iSharesSchwab

IBB top holdings

Top holdings · IBB
GILDGilead Sciences Inc8.94%
AMGNAmgen Inc8.31%
VRTXVertex Pharmaceuticals Inc7.87%
REGNRegeneron Pharmaceuticals Inc6.24%
MRNAModerna Inc5.49%
NTRANatera Inc3.78%
ARGXargenx SE ADR3.36%
BIIBBiogen Inc2.52%
RVMDRevolution Medicines Inc Ordinary Shares2.50%
ILMNIllumina Inc2.41%
Sector breakdown · IBB
Healthcare100.0%

SCHA top holdings

Top holdings · SCHA
HALOHalozyme Therapeutics Inc0.36%
GKOSGlaukos Corp0.34%
WWayfair Inc Class A0.32%
BMNRBitMine Immersion Technologies Inc0.29%
AHRAmerican Healthcare REIT Inc Ordinary Shares0.28%
BTSGBrightSpring Health Services Inc0.27%
RRyder System Inc0.26%
VSATViasat Inc0.26%
ENSGEnsign Group Inc0.25%
WTFCWintrust Financial Corp0.25%
Sector breakdown · SCHA
Real Estate6.9%
Consumer Cyclical11.1%
Basic Materials4.2%
Consumer Defensive2.9%
Technology15.1%
Communication Services2.8%
Financial Services16.9%
Utilities2.5%
Industrials14.5%
Energy5.8%
Healthcare17.3%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About SCHA

SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $22.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.12%. Its largest holding is Halozyme Therapeutics Inc (HALO), which represents 0.4% of the portfolio. Real Estate is the fund's largest sector exposure at 6.9%.